Evidence map›Paper›PMID 35061092›Full record

ArticleApplied microbiology and biotechnology2022

Biosynthesis and applications of iron oxide nanocomposites synthesized by recombinant Escherichia coli.

Jae Hwan Jung, Minkyung Cho, Tae Seok Seo, Sang Yup Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jae Hwan JungDepartment of Pharmaceutical Engineering, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan-si, 31116, Republic of Korea. jjaehwan@dankook.ac.kr.ORCID http://orcid.org/0000-0002-5738-5189
Minkyung ChoDepartment of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Tae Seok SeoDepartment of Chemical Engineering (BK21 FOUR Integrated Engineering Program), Kyung Hee University, 1 Seochon-dong, Giheung-gu, Yongin-si, Gyeonggi-do, 17140, Republic of Korea. seots@khu.ac.kr.
Sang Yup LeeDepartment of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Korea Advanced Institute of Science and Technology · KRDankook University · KRKyung Hee University · KR

Funding

Korea Food Research Institute funded by Ministry of Science and ICT of South Korea E0210701-01Ministry of Science and ICT 2020R1A2C1003960Ministry of Science and ICT (MSIT) 2021M3A9I4022740Ministry of Science, ICT and Future Planning 2021R1A5A6002853
6 · The paper itself

Abstract

Recombinant Escherichia coli (E. coli) strain that produces phytochelatin (PC) and/or metallothionein (MT) can synthesize various metal nanoparticles (NPs) by reducing metal ions. Here we report in vivo biosynthesis of iron oxide nanocomposites (NCs) using recombinant E. coli. We designed a strategy of biosynthesizing iron oxide NCs by first internalizing chemically synthesized iron oxide NPs, followed by the reduction of added metal ions on the surface of internalized NPs by PC and/or MT in E. coli. For this, chemically synthesized Fe

Indexed as

Metal NanoparticlesNanocompositesAnti-Bacterial AgentsEscherichia coliFerric CompoundsMicrobial Sensitivity TestsAnti-Bacterial AgentsFerric Compoundsferric oxideAntimicrobial activityBiosensorBiosynthesisNanocompositeRecombinant Escherichia coli

Identifiers

PMID35061092
OpenAlexW4205716944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.